rs762134268

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2

The NM_032776.3(JMJD1C):​c.2885C>T​(p.Ala962Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000665 in 1,579,140 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A962G) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000099 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000063 ( 0 hom. )

Consequence

JMJD1C
NM_032776.3 missense

Scores

1
18

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 1.27

Publications

1 publications found
Variant links:
Genes affected
JMJD1C (HGNC:12313): (jumonji domain containing 1C) The protein encoded by this gene interacts with thyroid hormone receptors and contains a jumonji domain. It is a candidate histone demethylase and is thought to be a coactivator for key transcription factors. It plays a role in the DNA-damage response pathway by demethylating the mediator of DNA damage checkpoint 1 (MDC1) protein, and is required for the survival of acute myeloid leukemia. Mutations in this gene are associated with Rett syndrome and intellectual disability. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2015]
JMJD1C Gene-Disease associations (from GenCC):
  • 22q11.2 deletion syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: LIMITED Submitted by: Illumina
  • neurodevelopmental disorder
    Inheritance: AD Classification: LIMITED Submitted by: G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.03913766).
BS2
High AC in GnomAd4 at 15 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
JMJD1CNM_032776.3 linkc.2885C>T p.Ala962Val missense_variant Exon 10 of 26 ENST00000399262.7 NP_116165.1 Q15652-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
JMJD1CENST00000399262.7 linkc.2885C>T p.Ala962Val missense_variant Exon 10 of 26 5 NM_032776.3 ENSP00000382204.2 Q15652-1
JMJD1CENST00000542921.5 linkc.2339C>T p.Ala780Val missense_variant Exon 9 of 25 1 ENSP00000444682.1 Q15652-3
JMJD1CENST00000402544.5 linkn.2857C>T non_coding_transcript_exon_variant Exon 7 of 22 1

Frequencies

GnomAD3 genomes
AF:
0.0000986
AC:
15
AN:
152068
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000459
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.0000882
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000605
AC:
13
AN:
215052
AF XY:
0.0000597
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000243
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000583
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000631
AC:
90
AN:
1426954
Hom.:
0
Cov.:
32
AF XY:
0.0000720
AC XY:
51
AN XY:
708440
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
31394
American (AMR)
AF:
0.000172
AC:
6
AN:
34838
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
24066
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39390
South Asian (SAS)
AF:
0.0000624
AC:
5
AN:
80186
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52302
Middle Eastern (MID)
AF:
0.000720
AC:
4
AN:
5554
European-Non Finnish (NFE)
AF:
0.0000627
AC:
69
AN:
1100344
Other (OTH)
AF:
0.000102
AC:
6
AN:
58880
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
6
11
17
22
28
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000986
AC:
15
AN:
152186
Hom.:
0
Cov.:
32
AF XY:
0.000108
AC XY:
8
AN XY:
74404
show subpopulations
African (AFR)
AF:
0.0000241
AC:
1
AN:
41530
American (AMR)
AF:
0.000458
AC:
7
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4822
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10582
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.0000882
AC:
6
AN:
67990
Other (OTH)
AF:
0.00
AC:
0
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000110
Hom.:
0
Bravo
AF:
0.0000756
ExAC
AF:
0.0000911
AC:
11

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Early myoclonic encephalopathy Uncertain:1
Nov 11, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces alanine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 962 of the JMJD1C protein (p.Ala962Val). This variant is present in population databases (rs762134268, gnomAD 0.03%). This variant has not been reported in the literature in individuals affected with JMJD1C-related conditions. ClinVar contains an entry for this variant (Variation ID: 529714). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt JMJD1C protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.099
BayesDel_addAF
Benign
-0.39
T
BayesDel_noAF
Benign
-0.51
CADD
Benign
19
DANN
Uncertain
0.99
DEOGEN2
Benign
0.014
.;T;.
Eigen
Benign
-0.20
Eigen_PC
Benign
-0.026
FATHMM_MKL
Benign
0.72
D
LIST_S2
Benign
0.83
T;T;T
M_CAP
Benign
0.0047
T
MetaRNN
Benign
0.039
T;T;T
MetaSVM
Benign
-0.99
T
MutationAssessor
Benign
1.2
.;L;.
PhyloP100
1.3
PrimateAI
Benign
0.36
T
PROVEAN
Benign
-0.92
.;N;N
REVEL
Benign
0.040
Sift
Benign
0.16
.;T;T
Sift4G
Benign
0.20
.;T;T
Polyphen
0.0
.;B;.
Vest4
0.13, 0.14
MutPred
0.11
.;Loss of loop (P = 0.1258);.;
MVP
0.30
MPC
0.066
ClinPred
0.049
T
GERP RS
4.2
Varity_R
0.055
gMVP
0.24
Mutation Taster
=88/12
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs762134268; hg19: chr10-64968544; API